The representative body of the innovative, prescription medicines industry in Australia, Medicines Australia is responsible for administering the Medicines Australia Code of Conduct. This self-regulatory system, underpinned by legislation, sets the standard for the ethical promotion and marketing of prescription medicines in Australia. These standards must be adhered to by member companies. Penalties for breaches of the Code of Conduct can be considerable and are increasing in severity year after year. Breaches of the Code and the resultant fines are published on the Medicines Australia website quarterly along with the comprehensive Code of Conduct Annual Report.
The Australian Clinical Trials Alliance (ACTA) has just concluded their International Clinical Trials conference, opened by the Federal Minister for Health Greg Hunt. As an indication of the interest in the topics the conference discussed, the official Conference Twitter hashtag #ACTAconf trended at number 4 in all of Australia!
As part of his presentation, Hunt launched an upgraded version of the Clin Trial Refer app which now delivers a comprehensive listing of clinical trials that are recruiting globally. Feedback from end-users and experts incorporated in this new Version 2 includes features such as customized searches that notify individual in real-time of trials in their areas of interest. Search filters such as age, tumour type, mutation status, and telehealth options can also be applied. The phase 1 cohort feature, among many new features, should improve recruiting. Pending studies and the cohorts being sought by investigators (including inclusion and exclusion criteria) can also be viewed to give patients and doctors opportunity to consider their participation.